首页> 美国卫生研究院文献>BMC Medical Research Methodology >Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: An example from a vertigo phase III study with longitudinal count data as primary endpoint
【2h】

Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: An example from a vertigo phase III study with longitudinal count data as primary endpoint

机译:贝叶斯模型选择技术作为制定临床试验统计分析计划的决策依据:以纵向计数数据为主要终点的眩晕III期研究的一个例子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundA statistical analysis plan (SAP) is a critical link between how a clinical trial is conducted and the clinical study report. To secure objective study results, regulatory bodies expect that the SAP will meet requirements in pre-specifying inferential analyses and other important statistical techniques. To write a good SAP for model-based sensitivity and ancillary analyses involves non-trivial decisions on and justification of many aspects of the chosen setting. In particular, trials with longitudinal count data as primary endpoints pose challenges for model choice and model validation. In the random effects setting, frequentist strategies for model assessment and model diagnosis are complex and not easily implemented and have several limitations. Therefore, it is of interest to explore Bayesian alternatives which provide the needed decision support to finalize a SAP.
机译:背景技术统计分析计划(SAP)是进行临床试验的方式与临床研究报告之间的关键链接。为了确保获得客观的研究结果,监管机构希望SAP能够满足预先指定推理分析和其他重要统计技术的要求。要为基于模型的敏感性和辅助分析编写好的SAP,需要对所选设置的许多方面做出非平凡的决策并证明其合理性。特别是,以纵向计数数据为主要终点的试验对模型选择和模型验证提出了挑战。在随机效应设置中,用于模型评估和模型诊断的频繁策略非常复杂且难以实施,并且存在一些局限性。因此,有必要探索贝叶斯替代方案,这些替代方案为最终确定SAP提供所需的决策支持。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号